Medication Review in Women With Depression and Anxiety

Not Applicable

Completed

• Conditions: Depression, Anxiety; Adherence, Patient
• Interventions: Other: Medication management review

• Registration Number: NCT04082871
• Lead Sponsor: Applied Science Private University

Brief Summary

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Detailed Description

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Study Timeline

• Study Start: 2016-08-01
• Primary Completion: 2017-01-01
• Study Completion: 2017-01-10
• Status Verified: 2019-09
• Study First Submitted: 2019-09-02
• Study First Submitted QC: 2019-09-06
• Last Update Submitted: 2019-09-06
• Study First Posted: 2019-09-09
• Last Update Posted: 2019-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 73

Inclusion Criteria

• Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period),
• above the age of 18 years
• diagnosed with depression and/or anxiety for at least 4 weeks duration
• taking medications for depression and/or anxiety

Exclusion Criteria

• presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist)
• being not able to speak or write Arabic (reported by the patient)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control	Medication management review	Control group patients also underwent the baseline interview with the researcher at the psychiatric clinic, TRPs were identified and documented. No intervention was provided by the pharmacist and no letter was sent to the patients' psychiatrists. In case a patient was found to have a life-threatening TRP, the patient was excluded from the study and reported to the psychiatrist due to ethical considerations. After study completion, all patients in the control group received the MMR service, and a letter with their TRPs and recommendations to resolve them was sent by the pharmacist to their psychologist
Intervention	Medication management review	All pharmacist level counseling and education regarding treatment, adherence and self-care activities were delivered to the active group patients only (planned to take 15 minutes). Patient level TRPs (any TRP that could be resolved via patient education and counseling) were resolved directly with the patient by the clinical pharmacist. A letter with the identified TRPs (prioritized from most important to least important) for each patient in the active group was sent to the patient's psychiatrist by the researcher in sealed envelopes. The psychiatrist either accepted or rejected the recommendations. In case the recommendations were accepted, the psychiatrist implemented the recommended changes. Patients were informed by a phone call by the pharmacist to visit their psychiatrist soon after the recommendations were approved for the changes to be applied. If the recommendations were rejected, the psychiatrist stated the reason of rejection and discussed it with the pharmacist.

Primary Outcome Measures

Name	Time	Method
Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety	6 months	the medication management review service will be measured by the reduction of treatment related number after providing the service

Secondary Outcome Measures

Name	Time	Method
Patient's satisfaction with the medication management review service	6 months	satisfaction will be measured by the willingness of patients to pay for the provided services